Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jingrong Jean Cui. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jingrong Jean Cui har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:TPTX / Turning Point Therapeutics Inc | Director | 540 383 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jingrong Jean Cui. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jingrong Jean Cui som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-06-10 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 540 383 | −0,06 | 67,48 | −20 244 | 36 465 045 |
2020-06-10 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 585 | 540 683 | −0,48 | 66,60 | −172 161 | 36 009 488 |
2020-06-10 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 515 | 543 268 | −0,82 | 65,80 | −297 087 | 35 747 034 |
2020-06-10 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 688 | 547 783 | −0,31 | 64,82 | −109 416 | 35 507 294 |
2020-06-10 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −412 | 549 471 | −0,07 | 63,80 | −26 286 | 35 056 250 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 961 | 549 883 | −1,07 | 63,92 | −381 027 | 35 148 521 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −10 667 | 555 844 | −1,88 | 63,36 | −675 861 | 35 218 276 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 872 | 566 511 | −0,33 | 62,50 | −117 000 | 35 406 938 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 568 383 | −0,23 | 65,66 | −85 358 | 37 320 028 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 671 | 569 683 | −0,81 | 65,03 | −303 755 | 37 046 485 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 927 | 574 354 | −1,53 | 64,04 | −571 685 | 36 781 630 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 602 | 583 281 | −0,61 | 63,04 | −227 070 | 36 770 034 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −828 | 586 883 | −0,14 | 69,54 | −57 579 | 40 811 844 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 072 | 587 711 | −0,35 | 68,62 | −142 181 | 40 328 729 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 800 | 589 783 | −0,30 | 67,52 | −121 536 | 39 822 148 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 591 583 | −0,10 | 65,81 | −39 486 | 38 932 077 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 012 | 592 183 | −0,67 | 64,67 | −259 456 | 38 296 475 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 688 | 596 195 | −0,61 | 63,88 | −235 589 | 38 084 937 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 599 883 | −0,60 | 62,70 | −225 720 | 37 612 664 |
2020-06-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 900 | 603 483 | −0,31 | 61,76 | −117 344 | 37 271 110 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 605 383 | −0,02 | 60,34 | −6 034 | 36 528 810 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 900 | 605 483 | −1,13 | 59,64 | −411 516 | 36 111 006 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 612 383 | −0,23 | 60,98 | −85 372 | 37 343 115 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 100 | 613 783 | −0,82 | 60,03 | −306 153 | 36 845 393 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 618 883 | −0,08 | 59,04 | −29 520 | 36 538 852 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 619 383 | −0,06 | 58,94 | −23 576 | 36 506 434 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 000 | 619 783 | −0,48 | 58,36 | −175 080 | 36 170 536 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 622 783 | −0,38 | 57,44 | −137 856 | 35 772 656 |
2020-05-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 625 183 | −0,19 | 56,33 | −67 596 | 35 216 558 |
2020-05-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 626 383 | −0,02 | 55,16 | −5 516 | 34 551 286 |
2020-05-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 750 | 626 483 | −0,75 | 54,49 | −258 828 | 34 137 059 |
2020-05-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 920 | 631 233 | −0,93 | 53,49 | −316 661 | 33 764 653 |
2020-05-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −730 | 637 153 | −0,11 | 52,53 | −38 347 | 33 469 647 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 330 | 637 883 | −0,21 | 53,70 | −71 421 | 34 254 317 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −11 864 | 639 213 | −1,82 | 53,05 | −629 385 | 33 910 250 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 306 | 651 077 | −0,81 | 52,22 | −277 079 | 33 999 241 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −12 428 | 656 383 | −1,86 | 53,13 | −660 300 | 34 873 629 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 072 | 668 811 | −0,90 | 52,54 | −319 023 | 35 139 330 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 784 | 674 883 | −0,85 | 54,67 | −316 211 | 36 895 854 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 718 | 680 667 | −1,26 | 54,04 | −471 121 | 36 783 245 |
2020-05-07 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 998 | 689 385 | −0,58 | 53,05 | −212 094 | 36 571 874 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 693 383 | −0,04 | 51,98 | −15 594 | 36 042 048 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 487 | 693 683 | −0,50 | 51,31 | −178 918 | 35 592 875 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 213 | 697 170 | −0,46 | 50,60 | −162 578 | 35 276 802 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 700 383 | −0,06 | 53,82 | −21 528 | 37 694 613 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 700 783 | −0,17 | 53,22 | −63 864 | 37 295 671 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 701 983 | −0,31 | 52,16 | −114 752 | 36 615 433 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 704 183 | −0,45 | 51,02 | −163 264 | 35 927 417 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 707 383 | −0,18 | 52,41 | −68 133 | 37 073 943 |
2020-04-24 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 700 | 708 683 | −0,80 | 51,64 | −294 348 | 36 596 390 |
2020-04-13 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −308 | 714 383 | −0,04 | 51,22 | −15 776 | 36 590 697 |
2020-04-13 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 714 691 | −0,03 | 49,87 | −9 974 | 35 641 640 |
2020-04-13 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 714 891 | −0,03 | 48,44 | −9 688 | 34 629 320 |
2020-04-13 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 892 | 715 091 | −0,26 | 48,75 | −92 235 | 34 860 686 |
2020-04-13 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 626 | 716 983 | −0,50 | 47,82 | −173 395 | 34 286 127 |
2020-04-13 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 982 | 720 609 | −0,82 | 46,81 | −280 017 | 33 731 707 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 726 591 | −0,01 | 47,22 | −4 722 | 34 313 260 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −12 106 | 726 691 | −1,64 | 46,43 | −562 082 | 33 740 263 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 294 | 738 797 | −0,84 | 45,88 | −288 800 | 33 899 700 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 900 | 745 091 | −0,79 | 45,63 | −269 217 | 33 998 502 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 100 | 750 991 | −1,07 | 44,96 | −364 176 | 33 764 555 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 500 | 759 091 | −0,59 | 43,69 | −196 605 | 33 164 686 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 763 591 | −0,04 | 45,13 | −13 539 | 34 460 862 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 890 | 763 891 | −0,38 | 44,22 | −127 796 | 33 779 260 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −11 212 | 766 781 | −1,44 | 43,72 | −490 189 | 33 523 665 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 998 | 777 993 | −0,38 | 42,61 | −127 745 | 33 150 282 |
2020-04-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 100 | 780 991 | −0,14 | 41,46 | −45 606 | 32 379 887 |
2020-03-27 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 782 091 | −0,03 | 48,06 | −9 612 | 37 587 293 |
2020-03-27 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 648 | 782 291 | −0,21 | 47,48 | −78 247 | 37 143 177 |
2020-03-27 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 052 | 783 939 | −0,39 | 46,55 | −142 071 | 36 492 360 |
2020-03-27 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 600 | 786 991 | −0,83 | 45,37 | −299 442 | 35 705 782 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 793 591 | −0,03 | 47,11 | −9 422 | 37 386 072 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 200 | 793 791 | −0,28 | 46,50 | −102 300 | 36 911 282 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −13 292 | 795 991 | −1,64 | 45,35 | −602 792 | 36 098 192 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 100 | 809 283 | −0,26 | 44,56 | −93 576 | 36 061 650 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 811 383 | −0,05 | 43,58 | −17 432 | 35 360 071 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 100 | 811 783 | −0,26 | 42,72 | −89 712 | 34 679 370 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 813 883 | −0,39 | 41,73 | −133 536 | 33 963 338 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 817 083 | −0,16 | 40,75 | −52 975 | 33 296 132 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 200 | 818 383 | −0,15 | 39,63 | −47 556 | 32 432 518 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 000 | 819 583 | −0,36 | 38,77 | −116 310 | 31 775 233 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 900 | 822 583 | −0,23 | 37,88 | −71 972 | 31 159 444 |
2020-03-25 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 824 483 | −0,11 | 36,52 | −32 868 | 30 110 119 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −701 | 825 383 | −0,08 | 37,91 | −26 575 | 31 290 270 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 878 | 826 084 | −0,23 | 36,94 | −69 373 | 30 515 543 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 821 | 827 962 | −0,22 | 36,07 | −65 683 | 29 864 589 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 600 | 829 783 | −0,31 | 34,96 | −90 896 | 29 009 214 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 832 383 | −0,17 | 43,72 | −61 208 | 36 391 785 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 200 | 833 783 | −0,38 | 42,86 | −137 152 | 35 735 939 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 836 983 | −0,29 | 41,50 | −99 600 | 34 734 794 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 800 | 839 383 | −0,80 | 40,61 | −276 148 | 34 087 344 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 700 | 846 183 | −0,55 | 40,02 | −188 094 | 33 864 244 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 400 | 850 883 | −0,40 | 43,33 | −147 322 | 36 868 760 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 000 | 854 283 | −0,93 | 42,42 | −339 360 | 36 238 685 |
2020-03-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −7 100 | 862 283 | −0,82 | 41,61 | −295 431 | 35 879 596 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
M - Exercise | −16 864 | 141 519 | −10,65 | ||||
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
M - Exercise | 16 864 | 890 383 | 1,93 | 5,12 | 86 344 | 4 558 761 | |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
M - Exercise | −30 000 | 158 383 | −15,93 | ||||
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
M - Exercise | −8 080 | 2 309 | −77,77 | ||||
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
M - Exercise | 30 000 | 873 519 | 3,56 | 5,12 | 153 600 | 4 472 417 | |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
M - Exercise | 8 080 | 843 519 | 0,97 | 3,20 | 25 856 | 2 699 261 | |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
M - Exercise | −54 220 | 188 383 | −22,35 | ||||
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
M - Exercise | 54 220 | 835 439 | 6,94 | 5,12 | 277 606 | 4 277 448 | |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 869 383 | −0,03 | 52,58 | −15 774 | 45 712 158 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 300 | 869 683 | −0,26 | 51,76 | −119 048 | 45 014 792 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 400 | 871 983 | −0,50 | 51,18 | −225 192 | 44 628 090 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 876 383 | −0,07 | 53,46 | −32 076 | 46 851 435 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −700 | 876 983 | −0,08 | 52,39 | −36 673 | 45 945 139 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 175 | 877 683 | −0,25 | 51,37 | −111 730 | 45 086 576 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 525 | 879 858 | −0,40 | 50,78 | −179 000 | 44 679 189 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 883 383 | −0,11 | 54,21 | −54 210 | 47 888 192 |
2020-02-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 000 | 884 383 | −0,67 | 53,62 | −321 720 | 47 420 616 |
2020-02-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 781 219 | −0,01 | 63,07 | −6 307 | 49 271 482 |
2020-02-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 800 | 781 319 | −1,11 | 62,18 | −547 184 | 48 582 415 |
2020-02-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 790 119 | −0,30 | 60,70 | −145 680 | 47 960 223 |
2020-02-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 792 519 | −0,03 | 59,83 | −11 966 | 47 416 412 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 792 719 | −0,04 | 66,80 | −20 040 | 52 953 629 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −12 400 | 793 019 | −1,54 | 66,19 | −820 756 | 52 489 928 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 800 | 805 419 | −0,71 | 65,31 | −378 798 | 52 601 915 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 250 | 811 219 | −0,52 | 63,88 | −271 490 | 51 820 670 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −14 250 | 815 469 | −1,72 | 63,03 | −898 178 | 51 399 011 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −9 249 | 829 719 | −1,10 | 63,14 | −583 982 | 52 388 458 |
2020-02-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −9 251 | 838 968 | −1,09 | 62,75 | −580 500 | 52 645 242 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 848 219 | −0,01 | 59,72 | −5 972 | 50 655 639 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 501 | 848 319 | −0,41 | 59,03 | −206 664 | 50 076 271 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 399 | 851 820 | −0,40 | 58,39 | −198 468 | 49 737 770 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 932 | 855 219 | −0,34 | 58,62 | −171 868 | 50 131 313 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 068 | 858 151 | −0,47 | 58,18 | −236 660 | 49 923 878 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 601 | 862 219 | −0,19 | 58,40 | −93 498 | 50 353 590 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 800 | 863 820 | −0,44 | 57,71 | −219 298 | 49 851 052 |
2020-01-29 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 599 | 867 620 | −0,18 | 56,82 | −90 855 | 49 298 168 |
2020-01-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 869 219 | −0,18 | 53,66 | −85 856 | 46 642 292 |
2020-01-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −9 900 | 870 819 | −1,12 | 53,03 | −524 997 | 46 179 532 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −10 101 | 880 719 | −1,13 | 54,06 | −546 060 | 47 611 669 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 009 | 890 820 | −0,56 | 53,30 | −266 980 | 47 480 706 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 390 | 895 829 | −0,38 | 52,44 | −177 772 | 46 977 273 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 899 219 | −0,04 | 54,21 | −21 684 | 48 746 662 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −10 194 | 899 619 | −1,12 | 53,11 | −541 403 | 47 778 765 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −7 906 | 909 813 | −0,86 | 52,49 | −414 986 | 47 756 084 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 734 | 917 719 | −0,19 | 58,83 | −102 011 | 53 989 409 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 291 | 919 453 | −0,14 | 58,38 | −75 369 | 53 677 666 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −10 525 | 920 744 | −1,13 | 57,95 | −609 924 | 53 357 115 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 250 | 931 269 | −0,45 | 56,79 | −241 358 | 52 886 767 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −400 | 935 519 | −0,04 | 55,75 | −22 300 | 52 155 184 |
2020-01-14 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −300 | 935 919 | −0,03 | 54,00 | −16 200 | 50 539 626 |
2020-01-08 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 55 000 | 55 000 | |||||
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 600 | 936 219 | −0,17 | 63,99 | −102 384 | 59 908 654 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 500 | 937 819 | −0,90 | 63,42 | −539 070 | 59 476 481 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 946 319 | −0,15 | 62,64 | −87 696 | 59 277 422 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 900 | 947 719 | −0,31 | 62,33 | −180 757 | 59 071 325 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 970 | 950 619 | −0,52 | 61,48 | −305 556 | 58 444 056 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −9 230 | 955 589 | −0,96 | 60,69 | −560 169 | 57 994 696 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 400 | 964 819 | −0,14 | 59,84 | −83 776 | 57 734 769 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 070 | 966 219 | −0,32 | 60,38 | −185 367 | 58 340 303 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −7 802 | 969 289 | −0,80 | 59,78 | −466 404 | 57 944 096 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 898 | 977 091 | −0,40 | 58,48 | −227 955 | 57 140 282 |
2019-12-20 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 730 | 980 989 | −0,38 | 57,76 | −215 445 | 56 661 925 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −305 | 984 719 | −0,03 | 62,71 | −19 127 | 61 751 728 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −6 495 | 985 024 | −0,66 | 62,05 | −403 015 | 61 120 739 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 100 | 991 519 | −0,81 | 61,13 | −495 153 | 60 611 556 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 600 | 999 619 | −0,36 | 60,30 | −217 080 | 60 277 026 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 1 003 219 | −0,02 | 60,43 | −12 086 | 60 624 524 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 400 | 1 003 419 | −0,24 | 59,76 | −143 424 | 59 964 319 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 000 | 1 005 819 | −0,49 | 58,75 | −293 750 | 59 091 866 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 1 010 819 | −0,13 | 57,59 | −74 867 | 58 213 066 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 000 | 1 012 119 | −0,20 | 56,84 | −113 680 | 57 528 844 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 1 014 119 | −0,06 | 55,45 | −33 270 | 56 232 899 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −600 | 1 014 719 | −0,06 | 56,95 | −34 170 | 57 788 247 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 800 | 1 015 319 | −0,37 | 56,17 | −213 446 | 57 030 468 |
2019-12-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −7 100 | 1 019 119 | −0,69 | 55,43 | −393 553 | 56 489 766 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 1 026 219 | −0,01 | 54,66 | −5 466 | 56 093 131 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −10 900 | 1 026 319 | −1,05 | 54,15 | −590 235 | 55 575 174 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 1 037 219 | −0,05 | 53,18 | −26 590 | 55 159 306 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −120 | 1 037 719 | −0,01 | 54,20 | −6 504 | 56 244 370 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 452 | 1 037 839 | −0,24 | 53,67 | −131 599 | 55 700 819 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 928 | 1 040 291 | −0,85 | 52,72 | −470 684 | 54 844 142 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −100 | 1 049 219 | −0,01 | 55,51 | −5 551 | 58 242 147 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 700 | 1 049 319 | −0,82 | 54,81 | −476 847 | 57 513 174 |
2019-12-12 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 700 | 1 058 019 | −0,25 | 53,79 | −145 233 | 56 910 842 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −200 | 1 060 719 | −0,02 | 56,78 | −11 356 | 60 227 625 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 200 | 1 060 919 | −0,39 | 55,94 | −234 948 | 59 347 809 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 100 | 1 065 119 | −0,38 | 55,35 | −226 935 | 58 954 337 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −3 000 | 1 069 219 | −0,28 | 54,33 | −162 990 | 58 090 668 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −14 263 | 1 072 219 | −1,31 | 51,02 | −727 698 | 54 704 613 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −36 627 | 1 086 482 | −3,26 | 50,67 | −1 855 890 | 55 052 043 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −22 630 | 1 123 109 | −1,98 | 52,84 | −1 195 769 | 59 345 080 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −12 200 | 1 145 739 | −1,05 | 52,08 | −635 376 | 59 670 087 |
2019-12-09 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
S - Sale | X | −21 280 | 1 157 939 | −1,80 | 50,93 | −1 083 790 | 58 973 833 |
2019-04-16 | 3 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
3 781 815 | ||||||||
2019-04-16 | 3 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
3 659 736 | ||||||||
2019-04-16 | 3 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
3 781 815 | ||||||||
2019-04-16 | 3 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
3 659 736 | ||||||||
2019-04-16 | 3 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
3 781 815 | ||||||||
2019-04-16 | 3 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
3 659 736 |